Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Threonine Phosphorylation Is a Bioreversible Surrogate of Proline Hydroxylation in a Collagen Triple Helix.

Journal of the American Chemical Society·2026
Same author

Reductive Methylation: An Alternative to Lysine → Arginine Mutagenesis.

Journal of peptide science : an official publication of the European Peptide Society·2026
Same author

A targetable opioid/cancer associated fibroblast axis drives extracellular matrix remodeling and tumor aggressiveness in pancreatic cancer.

bioRxiv : the preprint server for biology·2026
Same author

A peptide catalyst can replace an essential enzyme in a eukaryotic cell.

bioRxiv : the preprint server for biology·2026
Same author

NN-01-195, a novel conjugate of HSP90 and AURKA inhibitors, effectively targets solid tumors.

Molecular cancer therapeutics·2026
Same author

Nuclear Localization Signals Enable the Cellular Delivery of an Anti-CRISPR Protein to Control Genome Editing.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Jun 17, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.2K

Identifying and Targeting Key Driver Genes for Collagen Production within the 11q13/14 Breast Cancer Amplicon.

Daniela Araiza-Olivera1, Tatiana Y Prudnikova1, Cristina Uribe-Alvarez1

  • 1Cancer Signaling and Microenvironment Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Molecular Cancer Research : MCR
|January 21, 2025
PubMed
Summary

Researchers identified SERPINH1 and P4HA3 as key drivers in aggressive IntClust-2 breast cancers. Inhibiting these collagen synthesis genes offers a promising new therapeutic strategy for this poor-prognosis cancer type.

More Related Videos

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.5K
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.5K

Related Experiment Videos

Last Updated: Jun 17, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.2K
Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.5K
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.5K

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Integrative Cluster 2 (IntClust-2) breast cancers, marked by chromosome 11 amplification, exhibit poor patient survival (median 5 years).
  • Overexpression of driver genes in the amplified 11q13 region is hypothesized to cause aggressive tumor behavior and poor outcomes.

Purpose of the Study:

  • To identify novel driver genes within the 11q13 amplified region contributing to IntClust-2 breast cancer progression.
  • To evaluate the therapeutic potential of targeting identified driver genes, particularly those involved in collagen synthesis.

Main Methods:

  • Utilized gene editing to individually knock out 198 genes in the chromosome 11 amplified region.
  • Conducted in vitro and in vivo functional analyses to assess gene contributions to cancer cell viability, proliferation, and migration.
  • Tested a small-molecule inhibitor of P4HA3 in an animal model.

Main Results:

  • Identified SERPINH1 and P4HA3, involved in collagen synthesis, as critical drivers alongside known genes like CCND1 and PAK1.
  • Demonstrated that P4HA3 and/or SERPINH1 inhibition reduces collagen synthesis and impedes oncogenic signaling.
  • Showed that a P4HA3 inhibitor effectively reduced tumor growth in an animal model.

Conclusions:

  • SERPINH1 and P4HA3 play crucial roles in IntClust-2 breast cancer progression.
  • Targeting collagen synthesis pathways via P4HA3 or SERPINH1 inhibition presents a novel therapeutic avenue for IntClust-2 breast cancers.
  • These findings highlight the vulnerability of 11q13/14 amplified breast cancers to collagen synthesis inhibitors.